NGM Biopharma price target cut by more than half at Raymond James after NASH setback

Willow Biosciences poised to be the first company to commercially produce CBG, the "mother of all cannabinoids"

Canadian biotechnology company that produces high purity, plant-derived compounds for the global pharmaceutical, health and..